MASCCMultinational Association of Supportive Care in Cancer
References in periodicals archive ?
More recently, low-level laser therapy has been accepted as a valuable treatment option for OM by the MASCC (Multinational Association of Supportive Care in Cancer) and ISOO (International Society for Oral Oncology) [Keefe et al., 2007].
Importantly, the Multinational Association of Supportive Care in Cancer (MASCC) recently published a position statement that emphasizes the importance of adequate and integral supportive care, defined as management of both physical and psychological symptoms from diagnosis through the entire survivorship period (27).
It is the only drug of its class specifically recommended by the European Society of Medical Oncology (ESMO), and the Multinational Association of Supportive Care in Cancer (MASCC), for moderately emetogenic chemotherapy3.
In 2005, a panel of experts from the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Oral oncology reviewed the literature to create evidence-based guidelines for preventing, evaluating and treating oral mucositis, a summary of which can be found at (see list of resources).
En el ano 2000, Klastersky y colaboradores (25) publicaron el modelo de prediccion de riesgo de la Multinational Association for Supportive Care in Cancer (MASCC), basado en un estudio que analizo cerca de 1.000 episodios de neutropenia febril (Tabla no.
An oral history of MASCC, its origin and development from MASCC's beginnings to 2009.
Secondly, more reliable and valid instruments for CINV assessment such as the Functional Living Index Emesis (FLIE), MANE, MASCC Antiemesis Tool (MAT), or Index of Nausea, Vomiting, and Retching (INVR) should be considered in future studies [58].
Desde la conferencia de consenso de la Multinacional Association of Supportive Care of Cancer (MASCC) celebrada en Perugia en el ano 2004 (15), la mayoria de los autores aceptan la clasificacion de los citostaticos o combinaciones de ellos en funcion del riesgo emetogeno en farmacos de alto, moderado, bajo o minimo riesgo emetogeno (tabla 1).